로딩 중…
지수 로딩 중…
Parabilis Medicines Inc. Common Stock
PBLS· NASDAQ· Health Care
$28.70+1.88%
2026-10-29
Financials
Valuation Metrics
Parabilis Medicines Inc. Common Stock's Market Cap is $94M. Ranked #3065 of 3,115 in US market (top 98%), #1428 of 1,472 on NASDAQ (top 97%) by Market Cap.
Investment Metrics(as of 2026-10-29)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $94M | US#3,065/3,115 |
| Revenue | $0.00 | US#2,861/3,115 |
| Net Income | $-146M | US—/3,115 |
| Total Assets | $81M | US#3,061/3,115 |
| Net Assets | $-17M | US#2,924/3,115 |
| Employees | 145 | US#2,544/3,115 |
| Value | ||
| FCF Yield | -131.95% | US—/3,115 |
| Financial Health | ||
| Total Debt | $59M | US#2,574/3,115 |
| FCF | $-124M | US#2,682/3,115 |
| Cash | $28M | US#2,775/3,115 |
| Current Ratio | 0.52x | US#2,703/3,115 |
| Performance | ||
| 1M Return | -10.06% | US#2,723/3,115 |
| From 52W High | -32.45% | US#2,123/3,115 |
| 1Y MDD | -45.48% | US#2,201/3,115 |
| Trading | ||
| Volume | 840,090 shares | US#1,198/3,115 |
| Trading Value | $24M | US#1,498/3,115 |
| Per Share | ||
| EPS | $-44.55 | US—/3,115 |
| BPS | $-5.05 | US—/3,115 |
Company Info
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.